Institute for Protein Innovation
@ipiproteins
We advance protein science to accelerate research & improve human health | proteininnovation.org
IPI's recent Cell Systems article reports a novel framework to streamline #antibody development, generate ML-compatible datasets & identify functional binders missed by experimental selection. Read more ➡️ buff.ly/Qq5OnMu
Need a ROBO2 antibody? Anti-ROBO2 [IPI-ROBO2.47] just joined our Axon Guidance Antibody Collection. This (human) chimeric recombinant antibody has fused human variable and rabbit constant domains, and is recommended for flow cytometry and immunocytochemistry. Find out more: buff.ly/7OG3Ihl
Working with Neuroligins? IPI offers recombinant antibodies targeting NLGN1, NLGN2 and NLGN3. Our latest addition, IPI-NLGN1.15, is selective (non-cross-reactive with other NLGNs) and recommended for use in flow, IF and IHC. View the validation data and learn more: buff.ly/mOTAfGY #Neuroligin
That's a wrap on IPI's recent Introduction to Automated Liquid Handling course! Thanks to our participants, and to @sptlabtech.bsky.social and @novabiomedical.bsky.social for their support. More protein science courses are coming—join our mailing list for education updates: buff.ly/nzyAQUW
IPI often hears about a mismatch between traditional lab coursework and real bioscience needs. To fill that gap, we joined Emmanuel College students this week to offer technical skills in lab automation plus insights into when/how to apply those skills. Here's what that looks like ⬇️
Two new antibodies just hit our collections! ➕ Anti-ROBO2 [IPI-ROBO2.47] ➕ Anti-Neuroligin-1 [IPI-NLGN1.15] Explore our recombinant antibodies for ROBOs, Neuroligins and other axon guidance and synaptic cleft targets: buff.ly/nIfPvy6 #Robo #Neuroligin
Last chance to register for IPI's Introduction to Automated Liquid Handling course. Hands-on OT-2 training, Python-based method development, automation workflow design, and expert-led discussions. 📅 July 23-24 📍 Boston Register now: buff.ly/e89E45Y
Did you know that IPI has stores of antibodies ready for your lab’s next experiment? We understand the setbacks of bad antibodies and strive for you to be able to trust your results. Explore our collections and order today 🧪 buff.ly/6R9zi4n
Scale-up and automate your workflows with IPI’s two-day interactive course, July 23-24, featuring: Lectures on the core principles of automated liquid handling Q&As w/ IPI lab experts & an automated systems tour Liquid handler experience & method development w/ Python Register now: buff.ly/YWG7qhs
Researchers across academia and industry, in labs small and large, are using automation to improve reproducibility and scale workflows. Learn the fundamentals in IPI's hands-on course this July. Register: buff.ly/TVFyfbB
New antibody alert 🧪Anti-NRXN3a just joined our Synaptic Cleft Antibody Collection. Order now: buff.ly/VwjVHuw #Neurexin
New to #labautomation? IPI's Intro to Automated Liquid Handling course is designed for researchers at all experience levels. Learn liquid handling fundamentals, build workflows on an Opentrons OT-2, and explore real-world automation systems used in #antibodydiscovery. Register ➡️ buff.ly/sTTJvBQ
A look back to IPI’s yeast display course earlier this month! What an amazing cohort, determined to expand their grasp of display technologies and bring these lessons back to labs around the world. Our next course, an intro to lab automation, is happening July 23-24 — sign up now! buff.ly/E2K6ytH
Meet #AlloyScholar Shelby Harris! Shelby, a @vanderbilt.edu PhD student, joined our 2026 Yeast Display course to learn #Abengineering methods to study G6P's role in #glucoseproduction. Thanks Alloy Therapeutics for supporting this year’s Scholars! Get IPI updates: buff.ly/a7XyBij
Just out @cellpress.bsky.social! Led by Deepash Kothiwal & co-authored by 20+ IPI lab members, the paper reports a novel framework to streamline antibody development, generate ML-compatible datasets and identify functional binders missed by experimental selection. Read the paper: buff.ly/Qq5OnMu
Looking for a dependable #isotypecontrol antibody? Our #MOPC-21 recombinant rabbit IgG is compatible with all IPI rabbit IgG antibodies and, as a consistent non-binder, supports accurate assessment of family-wide cross-reactivity. Order now: buff.ly/gU0M1ZE
#AlloyScholar Lorenzo Agostini (NIH) joined IPI’s #YeastDisplay course this month to learn cutting-edge antibody discovery and engineering techniques alongside fellow translational researchers. Thanks, Alloy Therapeutics, for the support! Get IPI education updates: buff.ly/a7XyBij
Scale-up and automate your workflows! Join us for a two-day interactive course, happening July 23-24. Register now: buff.ly/GWBG1yq
Last week’s course was a big success, thanks to our guest speakers! Dane Wittrup @mitkochinstitute.bsky.social, Surge Biswas at Nabla Bio & Justin Peruzzi @aiproteins.com shared insights on yeast display, AI Ab design & miniprotein discovery. Sign up for future course updates ➡️ buff.ly/tTcDWZk
Researchers at IPI and Alloy Therapeutics are hoping AI advances will help make drug discovery less expensive, faster and better — especially when it comes to nanobody therapeutics. Read more: buff.ly/8ZBqnYs
It’s the last day of a great week training on #antibodydiscovery techniques, practicing cell sorts, and learning all about the utility of yeast display! Thanks to Sony Biotechnology the support & sharing #flowcytometry/#cellsorting insights! Get IPI ed pdates: buff.ly/ZKR3alr
Another day of #yeastdisplay! Today, students learned #antigenbiotinylation, #FACS, and #AIproteindesign. Thanks to today’s sponsor, Alloy Therapeutics, for sharing more on #antibodydiscovery via mammalian cell-based directed evolution! News on courses and events: buff.ly/ZKR3alr
Our #yeastdisplay course is off to a great start with an intro to the basics of #displaytechnology, #librarycreation & #cellsorting. Thank you to sponsor @twistbioscience.com & Steven Thomas for offering strategies to build effective/diverse libraries! Find out about future courses: buff.ly/ZKR3alr
Still thinking about the conversations & energy from last week at the Forbes #America250 Expo! It was inspiring to connect with so many people, share more about IPI's role in #basicresearch & #drugdiscovery, and celebrate the many achievements of our founder @timothyspringer.bsky.social!
Join us in Boston this July for an intensive, hands-on training led by IPI’s automation team & sponsored by SPT Labtech. Register to learn the basics of #liquidhandling, #methoddevelopment and #automation for #antibodydiscovery ➡️ buff.ly/3f3vP8Y 📅 July 23–24, 2026 📍 Boston, MA 👥 Only 5 spots left
Spend two days with IPI automation experts this summer 🤝 Start automating workflows in your lab Sign up for our “Introduction to Automated Liquid Handling” course, happening right here in Boston July 23-24, 2026. Sign up now: buff.ly/viOaakH
It's been a busy week! Our team flooded #PEGSBoston with posters and a lab automation short course, presented at @canacn.bsky.social's Montréal meeting alongside @addgene.bsky.social & made a special appearance at #Forbes250 in SF! Great to connect with collaborators and share our science!
Scale-up and automate your workflows with IPI’s interactive course, July 23-24, featuring: Lectures + Q&As with IPI experts A tour of automated systems for protein science Robots + method development skills A lunch + learn from our sponsor, SPT Labtech Register now: buff.ly/MR3iVXI
What’s a VHH? Think of it like a tiny Lego-like antibody with untapped therapeutic potential. Learn more about how IPI and Alloy Therapeutics are partnering to put them to use: buff.ly/pfaRBaa
